Related Experiment Videos
Precocious aging and dementia in patients with Down's syndrome
Biological Psychiatry
|October 1, 1978
Summary
This study shows that individuals with Down's syndrome (DS) experience accelerated aging and cognitive decline, particularly after age 35. Neurological and psychiatric issues, including memory loss, are common in DS patients, indicating central nervous system changes.
Area of Science:
- Gerontology
- Neuroscience
- Genetics
Background:
- Down's syndrome (DS) is a chromosomal abnormality associated with premature aging and cognitive deficits.
- Understanding the clinical progression of aging and neurological deterioration in DS is crucial for patient care.
Purpose of the Study:
- To investigate the clinical course of precocious aging and mental/neurological deterioration in institutionalized patients with Down's syndrome.
- To identify specific neurological, psychiatric, and cognitive changes associated with aging in DS.
Main Methods:
- Studied fifty unselected institutionalized patients with Down's syndrome.
- Analyzed clinical data to establish differences in neurological and psychiatric abnormalities and mental deterioration based on age (below and above 35).
Main Results:
- Statistically significant differences in neurological and psychiatric abnormalities and mental deterioration were found in patients above 35 years old.
- Increased incidence of recent memory loss, impaired short-term visual retention, frontal release signs, hypertonia, hyperreflexia, long-tract signs, and psychiatric problems were observed.
- External features of precocious aging were noted in the study cohort.
Conclusions:
- Down's syndrome exhibits progressive central nervous system changes indicative of accelerated aging and dementia.
- DS serves as a model for studying genetically determined biochemical defects leading to precocious aging and dementia.